Year

IP Cases — 2024

4,764 decisions across all jurisdictions

By type: patent 4493 trademark 249 copyright 16 design 3 other 2 trade-secret 1

Page 113 of 159 · 4,764 total

patent denied · Apr 19, 2024

Vectair Systems Inc. v.Fresh Products, Inc.

· IPR2024-00824

Vectair Systems Inc.'s IPR challenge against Fresh Products, Inc.'s patent was denied by the PTAB. The Board found that the Petitioner failed to establish a reasonable likelihood of prevailing on grounds of anticipation (102) or obviousness (103).

patent instituted · Apr 19, 2024

Cellco Partnership d/b/a Verizon Wireless et al. v.Headwater Partners I LLC

· IPR2024-00809

The PTAB instituted the IPR challenge against Verizon Wireless's patent (9198042), finding a reasonable likelihood of prevailing on grounds of obviousness. The Board accepted Petitioner's arguments that prior art references could be combined to teach secure execution environments for mobile data services.

patent instituted · Apr 19, 2024

Google LLC v.Proxense, LLC

· IPR2024-00783

Google LLC successfully argued that the challenged claims were obvious over multiple combinations of prior art (Dua, Giobbi ’157, Kotola, Buer). The PTAB instituted the IPR on all 20 challenged claims after rejecting the Patent Owner's narrow claim construction arguments. This sets up a significant trial phase regarding wireless security and digital key technology.

patent instituted · Apr 19, 2024

United Services Automobile Association v.Auto Telematics Ltd.

· IPR2024-00779

United Services Automobile Association (USAA) successfully argued that the patent claims related to telematics and driving safety systems were obvious under 35 U.S.C. § 103. The PTAB found a reasonable likelihood of prevailing on its assertion, advancing the IPR proceedings against Auto Telematics Ltd.'s '878 patent.

patent instituted · Apr 19, 2024

Samsung Electronics Co. Ltd et al. v.Maxell, Ltd.

· IPR2024-00735

The PTAB institution decision granted IPR for Samsung against Maxell regarding video management systems. The Board found sufficient evidence that the challenged claims were obvious over various combinations of prior art references, including Horn and Baumgartner. This moves the case into substantive examination on obviousness grounds.

patent instituted · Apr 19, 2024

Samsung Electronics Co. Ltd. et al. v.Maxell, Ltd.

· IPR2024-00717

The PTAB instituted IPR against Maxell, Ltd.'s patent claims related to camera control systems. The Board declined discretionary denial despite parallel district court litigation because the petitioner agreed not to assert the same grounds there.

patent final · Apr 19, 2024

Cellco Partnership d/b/a Verizon Wireless et al. v.Headwater Partners I LLC

· IPR2024-00809

The Board found all 18 challenged claims unpatentable under 35 U.S.C. § 103 (obviousness). The Petitioner successfully argued that the combination of prior art references, including Limont, Wright, and Xu, disclosed the claimed invention. This final decision provides a strong defense against infringement claims in wireless communications technology.

patent Final Written Decision · Apr 19, 2024

Samsung Electronics Co. Ltd et al. v.Maxell, Ltd.

· IPR2024-00777

The PTAB issued a Final Written Decision denying unpatentability for claims 16-27. The Board found that the Petitioner failed to prove obviousness against various prior art combinations, particularly regarding limitations related to user profiles and shared video information.

patent Final Written Decision · Apr 19, 2024

Samsung Electronics Co. Ltd et al. v.Maxell, Ltd.

· IPR2024-00735

The PTAB found that claims 1-6 and 9-13 were unpatentable over Kaplan and Bryant under 35 U.S.C. § 103, while rejecting the challenge to claims 7, 8, 14, and 15 due to insufficient evidence of prior art accessibility. The Board adopted the Patent Owner's construction for 'user profile,' aligning with district court findings.

patent final · Apr 19, 2024

Samsung Electronics Co. Ltd. et al. v.Maxell, Ltd.

· IPR2024-00717

The PTAB found all 11 challenged claims unpatentable by obviousness (35 U.S.C. § 103). Petitioner successfully demonstrated that combining various prior art references—including Chinn, Takahashi, and Kim—would render the claimed features obvious to a Person Having Ordinary Skill in the Art (POSITA).

other interim order · Apr 19, 2024

Mahyco Monsanto Biotech India Pvt. Ltd. v.The State Of Telangana, Represented By ...

Telangana High Court · 92613220

Mahyco Monsanto Biotech filed an appeal against a single judge's order regarding the fixation of reasonable trait value/royalty for cotton seeds by the State of Telangana. The court heard arguments concerning potential prejudice to the petitioners if the impugned order was suspended. Ultimately, the court decided to suspend the challenged government order until the next hearing date.

patent mixed · Apr 19, 2024

Jk Lakshmi Cement Ltd. v.Kana Ram Kalirana & Anr.

Gujarat High Court · 24903381

The Gujarat High Court disposed of a rectification petition filed by Jk Lakshmi Cement Ltd. against Kana Ram Kalirana & Anr. The court noted that the parties had entered into a settlement in another suit, wherein Respondent No. 1 undertook to abandon the impugned trademark registration. Consequently, the court directed the Trade Marks Registry to expedite the processing of the withdrawal application filed by the respondent, effectively allowing the matter to be resolved through administrative action.

patent · Apr 18, 2024

Daedalus Prime LLC v.Xiaomi Technology Netherlands B.V., Xiaomi Inc., Xiaomi Technology Germany GmbH, MediaTek Inc. (Headquarters), Xiaomi Communications Co., Ltd.

Hamburg (DE) Local Division · UPC-001531

This is a procedural order from the Hamburg Local Division of the Court of First Instance concerning an infringement action relating to European Patent EP2792100, owned by Daedalus Prime LLC. The plaintiff sought permission to serve process on the Chinese defendants (Xiaomi Communications Co., Ltd. and Xiaomi Inc.) and the Taiwanese defendant (MediaTek Inc.) via their respective German branch offices under Rule 271.5(a) of the Rules of Procedure. The plaintiff argued that the German branches operate with sufficient independence and autonomy to qualify as places of business through which service could validly be effected.

patent · Apr 18, 2024

Pharaoh Energy Services, LLC v.Flex-Chem Holding Company, LLC et al.

· IPR2024-00822

Pharaoh Energy Services has filed an IPR petition seeking to invalidate Flex‑Chem’s 9,944,843 well‑stimulation patent. The petition relies on Frenier and Reyes as prior art to argue anticipation and obviousness of all 13 claims. The Board has yet to decide whether to institute the review.

patent · Apr 18, 2024

Abbott Diabetes Care Inc. et al. v.DexCom, Inc.

· IPR2024-00797

Abbott Diabetes Care and DexCom filed a joint PTAB request to keep their settlement agreement confidential under §317(b) and related regulations.

patent denied · Apr 18, 2024

Micron Technology, Inc. et al. v.Yangtze Memory Technologies Company, Ltd.

· IPR2024-00790

Micron’s request for Director Review of IPR2024-00790 was denied after the Patent Owner filed a Notice of Appeal, which stripped the PTAB of jurisdiction. The Board cited In re Graves in reaching its decision.

patent · Apr 18, 2024

Micron Technology, Inc. et al. v.Yangtze Memory Technologies Company, Ltd.

· IPR2024-00790

Micron Technology seeks Director Review of the PTAB’s decision that claim 4 of its 3‑D NAND patent remains unpatentable. The petition argues the Board misapplied obviousness law, ignoring KSR precedent and the known‑substitute teaching of Kim and Tessariol.

patent · Apr 18, 2024

Abbott Diabetes Care Inc. et al. v.DexCom, Inc.

· IPR2024-00797

Abbott Diabetes Care and DexCom have filed a joint motion to terminate IPR2024‑00797 after reaching a confidential settlement and license agreement covering the ’222 patent.

patent denied · Apr 18, 2024

Micron Technology, Inc. et al. v.Yangtze Memory Technologies Company, Ltd.

· IPR2024-00790

Micron’s request for Director Review of the PTAB’s decision on claim 4 of Yangtze Memory’s 3D memory patent was denied. The Board affirmed that Micron failed to demonstrate a motivation or benefit for the alleged modification.

patent terminated or settled · Apr 18, 2024

Abbott Diabetes Care Inc. et al. v.DexCom, Inc.

· IPR2024-00797

Abbott Diabetes Care and DexCom settled their dispute over a continuous glucose monitoring patent, leading the PTAB to terminate the IPR by joint request.

patent · Apr 18, 2024

Micron Technology, Inc. et al. v.Yangtze Memory Technologies Company, Ltd.

· IPR2024-00790

Micron has requested a Director Review of the IPR decision against Yangtze Memory Technologies. The Patent Owner has five business days to file a concise response limited to the issues raised, with no new evidence allowed.

patent all challenged claims upheld · Apr 18, 2024

CISCO SYSTEMS, INC. et al. v.InfoExpress Inc.

· IPR2024-00679

InfoExpress successfully defended its NAC patent against Cisco and Fortinet’s Director Review request, with the PTAB upholding all challenged claims. The Board found the antedating evidence properly presented and rejected the petitioners’ untimely arguments.

patent · Apr 18, 2024

CISCO SYSTEMS, INC. et al. v.InfoExpress Inc.

· IPR2024-00675

Cisco and Fortinet have filed a Request for Director Review seeking to vacate the PTAB's final written decision on the ’484 patent. They allege the Board improperly allowed the patent owner to incorporate arguments by reference, violating USPTO rules and breaching the burden of conception and diligence.

patent denied · Apr 18, 2024

CISCO SYSTEMS, INC. et al. v.InfoExpress Inc.

· IPR2024-00675

The USPTO denied Cisco’s request for Director Review of the final written decisions in multiple IPRs, including the case involving patent 7,523,484. The denial leaves the patent owner’s rights intact.

patent null · Apr 18, 2024

Valeo SE et al. v.Foras Technologies Limited

· IPR2024-00823

Valeo SE et al. filed a Petition challenging claims of Foras Technologies Limited's patent (7502958) on grounds of obviousness and anticipation. The petitioners argue that the claimed fault-tolerant processor architecture is rendered obvious by combining Bigbee and Nguyen prior art references.

patent null · Apr 18, 2024

Micron Technology, Inc. et al. v.Yangtze Memory Technologies Company, Ltd.

· IPR2024-00790

Micron Technology filed a Petition challenging the validity of Yangtze Memory Technologies' '031 Patent, arguing that key claims are obvious over prior art references Kim and Tessariol. The petition focuses on 3D NAND memory structures, specifically multi-stack staircase designs and etch profiles. Micron asserts that the combination of teachings from these references renders the claimed features predictable and non-novel.

patent null · Apr 18, 2024

CISCO SYSTEMS, INC. et al. v.InfoExpress Inc.

· IPR2024-00679

CISCO and FORTINET filed a Petition challenging 18 claims of InfoExpress's U.S. Patent No. 7,523,484 in the PTAB. The petitioners argue that the network access methods are obvious under 35 U.S.C. § 103 based on prior art references Krantz and Herrmann. This challenge is part of ongoing litigation against InfoExpress in District Court.

patent null · Apr 18, 2024

CISCO SYSTEMS, INC. et al. v.InfoExpress Inc.

· IPR2024-00675

CISCO SYSTEMS challenges InfoExpress's 7523484 Patent in an IPR, asserting that the network security claims are obvious under 35 U.S.C. § 103. The petitioner argues that prior art references (Krantz and Herrmann) disclose nearly identical architecture to the patented invention, making the claims unpatentable.

patent denied · Apr 18, 2024

Pharaoh Energy Services, LLC v.Flex-Chem Holding Company, LLC et al.

· IPR2024-00822

The PTAB denied the petition to challenge claims in a well remediation patent, finding that the petitioner failed to demonstrate sufficient novelty or obviousness against prior art references. The Board relied heavily on the proximity of parallel district court litigation when applying Fintiv factors for discretionary denial.

patent instituted · Apr 18, 2024

Abbott Diabetes Care Inc. et al. v.DexCom, Inc.

· IPR2024-00797

Abbott Diabetes Care challenged DexCom's CGM patents in an IPR, arguing the claims are obvious over prior art combining Yarger and Love. The Board granted institution after claim construction, finding a reasonable likelihood of unpatentability for at least one claim.

Arctic Invent — IP Strategy

Facing a similar IP matter?

Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.

Consult our team →